Semaglutide vs Ozempic: are they the same?

Ozempic contains semaglutide. Semaglutide is the active ingredient; Ozempic is a brand of prescription medicine made by Novo Nordisk. They are not two competing ingredients. However, a product described only as "semaglutide" is not necessarily Ozempic, FDA-approved, or interchangeable with your prescription.

Semaglutide also appears in Wegovy and Rybelsus. To compare medicines meaningfully, identify the brand, formulation and reason it was prescribed. The manufacturer's explanation of Ozempic tablets confirms that its oral and injectable products contain the same semaglutide molecule.

Comparing another preparation? Jump to semaglutide with B12 or HCG vs Ozempic.

By USAHCG · Originally published October 28, 2023 · Updated November 2, 2026. This U.S. labeling overview is educational. Your prescriber or pharmacist should advise on your medication.

Ozempic, Wegovy and Rybelsus compared

The table summarizes selected approved uses. Eligibility and instructions differ by product and formulation; the linked prescribing information gives the full details. Scroll sideways on small screens.

Product	Form and frequency	Selected U.S. approved uses
Ozempic injection	Weekly injection	For adults with type 2 diabetes: blood sugar management; cardiovascular risk reduction when cardiovascular disease is established; reduced risk of kidney deterioration, kidney failure and cardiovascular death when chronic kidney disease is present.
Ozempic tablets and Rybelsus	Daily tablets with different strengths	Blood sugar management in adults with type 2 diabetes; cardiovascular risk reduction in adults with type 2 diabetes at high risk of these events.
Wegovy injection	Weekly injection	Weight management in eligible adults and adolescents aged 12 or older; cardiovascular risk reduction in eligible adults; certain adults with noncirrhotic MASH and moderate to advanced liver fibrosis.
Wegovy tablets	Daily tablets	Weight management and cardiovascular risk reduction in eligible adults. The injection's adolescent and MASH indications do not apply to the tablets.

Sources: Ozempic injection label, Ozempic tablets and Rybelsus label, and Wegovy label. These products are used with the diet and activity measures specified in their labels.

Wegovy's adult weight-management indication covers obesity, or overweight with a weight-related condition. Its adolescent indication requires obesity. Cardiovascular prevention requires established cardiovascular disease and overweight or obesity. MASH means metabolic dysfunction-associated steatohepatitis; that liver-disease indication has accelerated approval.

Is Ozempic only an injection?

No. Current U.S. labeling includes Ozempic tablets as well as injections. Describing Rybelsus as the only semaglutide pill is also outdated: Wegovy has a tablet formulation too.

The name alone no longer tells you how a medicine is taken. Check whether the prescription specifies a tablet or injection, and which strength and device it names. The manufacturer's diabetes product directory lists the oral and injectable Ozempic products separately.

Are their doses equivalent?

No. An oral milligram amount cannot be treated as the equivalent injection dose. Even the two diabetes tablet products differ: the combined tablet label lists Ozempic strengths of 1.5, 4 and 9 mg, and Rybelsus strengths of 3, 7 and 14 mg. It explicitly says they cannot be substituted milligram for milligram.

Ozempic injection has a maximum labeled dose of 2 mg weekly. Wegovy's current injection label includes a 7.2 mg presentation, so older comparisons calling 2.4 mg its universal maximum are outdated. Dose selection depends on the indication and patient. These numbers are product differences, not instructions for starting treatment or switching.

Have your prescriber and pharmacist confirm any change. Do not transfer a schedule or syringe measurement from another product.

Is compounded semaglutide the same as Ozempic?

No. A compounded preparation is not the FDA-approved Ozempic product. FDA does not review compounded drugs for safety, effectiveness and quality before marketing. It advises using them only when a patient's medical needs cannot be met by an approved drug. See the FDA's guidance on unapproved GLP-1 products.

That guidance also distinguishes semaglutide sodium and semaglutide acetate from the active ingredient in approved medicines. FDA says these salt forms should not be used to compound semaglutide. A similar ingredient name does not establish equivalence.

With compounded injections, concentrations and measuring instructions can vary. FDA has reported dosing errors, including cases requiring hospitalization. Ask the dispensing pharmacist to explain the prescribed amount and the specific syringe before using a product with unclear instructions. See the FDA dosing-error alert.

What about semaglutide with B12 or cyanocobalamin?

Cyanocobalamin is a form of vitamin B12 that some compounders add to semaglutide. That mixture is not Ozempic. The FDA's compounding alert says the safety and effectiveness of combining semaglutide with additional ingredients has not been established. Adding B12 does not establish that a preparation works better or is equivalent to an approved product.

Does "generic semaglutide" mean an approved generic?

Not by itself. Semaglutide is an ingredient name. FDA approval of a generic medicine is a separate process involving the finished product, including evidence of equivalence to its reference drug. A seller's wording does not establish that approval. The FDA's generic-drug guide explains the distinction. Ask a pharmacist to identify the exact product and verify its approval status.

Which is better for weight loss or side effects?

Comparing "semaglutide versus Ozempic" cannot answer that question because Ozempic already contains semaglutide. Ozempic's U.S. indications do not include weight management; Wegovy has weight-management indications. That distinction does not establish which prescription is appropriate for an individual.

Semaglutide can cause nausea, vomiting, diarrhea, constipation and abdominal pain. Serious risks include pancreatitis and severe gastrointestinal reactions. Its boxed warning concerns thyroid C-cell tumors observed in rodents; the risk in humans is unknown. Ozempic is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. See the manufacturer's safety information. Calling a preparation "semaglutide" does not make these risks disappear.

HCG vs Ozempic: are they related?

HCG stands for human chorionic gonadotropin. It is a hormone and a different medication from semaglutide, the ingredient in Ozempic. FDA has approved prescription HCG for certain medical uses, including female infertility, but HCG is not approved for weight loss. FDA also warns about the severe calorie restriction promoted with HCG diets. These medicines should not be presented as interchangeable weight-loss treatments.

Bring the product name and packaging to your pharmacist if the wording is confusing. Ask what it contains, whether it is approved or compounded, and which instructions apply. For other educational articles, browse the USAHCG blog.